메뉴 건너뛰기




Volumn 17, Issue 11, 2011, Pages 763-769

Targeting of hepatocellular carcinoma with glypican-3-targeting peptide ligand

Author keywords

Glypican 3; Hepatocellular carcinoma; Peptide ligand; Proteomics; Tumor targeting

Indexed keywords

AMINO ACID DERIVATIVE; GLYPICAN 3; HYBRID PROTEIN; LIPOSOME;

EID: 80054991465     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1400     Document Type: Article
Times cited : (31)

References (23)
  • 1
    • 79958258113 scopus 로고    scopus 로고
    • Potent, tumor-specific gene expression in an orthotopic hepatoma rat model using a survivin-targeted, amplifiable adenoviral vector
    • Ahn BC, Ronald JA, Kim YI, Katzenberg R, Singh A, Paulmurugan R, Ray S, Hofmann LV, Gambhir SS. Potent, tumor-specific gene expression in an orthotopic hepatoma rat model using a survivin-targeted, amplifiable adenoviral vector. Gene Ther. 2011; 18: 606-612.
    • (2011) Gene Ther. , vol.18 , pp. 606-612
    • Ahn, B.C.1    Ronald, J.A.2    Kim, Y.I.3    Katzenberg, R.4    Singh, A.5    Paulmurugan, R.6    Ray, S.7    Hofmann, L.V.8    Gambhir, S.S.9
  • 2
    • 79251599238 scopus 로고    scopus 로고
    • Glypican-3: a new target for cancer immunotherapy
    • Ho M, Kim H. Glypican-3: a new target for cancer immunotherapy. Eur. J. Cancer 2011; 47: 333-338.
    • (2011) Eur. J. Cancer , vol.47 , pp. 333-338
    • Ho, M.1    Kim, H.2
  • 3
    • 0035086268 scopus 로고    scopus 로고
    • Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders
    • Zhu ZW, Friess H, Wang L, Abou-Shady M, Zimmermann A, Lander AD, Korc M, Kleeff J, Buchler M. Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders. Gut 2001; 48: 558-564.
    • (2001) Gut , vol.48 , pp. 558-564
    • Zhu, Z.W.1    Friess, H.2    Wang, L.3    Abou-Shady, M.4    Zimmermann, A.5    Lander, A.D.6    Korc, M.7    Kleeff, J.8    Buchler, M.9
  • 5
    • 33747698690 scopus 로고    scopus 로고
    • Recent developments in the first detection of hepatocellular carcinoma
    • Lopez JB. Recent developments in the first detection of hepatocellular carcinoma. Clin. Biochem. Rev. 2005; 26: 65-79.
    • (2005) Clin. Biochem. Rev. , vol.26 , pp. 65-79
    • Lopez, J.B.1
  • 7
    • 38449095281 scopus 로고    scopus 로고
    • Glypican-3 immunocytochemistry in liver fine-needle aspirates. A novel stain to assist in the differentiation of benign and malignant liver lesions
    • Kandil D, Leiman G, Allegretta M, Trotman W, Pantanowitz L, Goulart R, Evans M. Glypican-3 immunocytochemistry in liver fine-needle aspirates. A novel stain to assist in the differentiation of benign and malignant liver lesions. Cancer 2007; 111: 316-322.
    • (2007) Cancer , vol.111 , pp. 316-322
    • Kandil, D.1    Leiman, G.2    Allegretta, M.3    Trotman, W.4    Pantanowitz, L.5    Goulart, R.6    Evans, M.7
  • 12
    • 84855209928 scopus 로고    scopus 로고
    • Peptide heterodimers for molecular imaging
    • DOI: 10.1007/s00726-010-0546-y
    • Yan Y, Chen X. Peptide heterodimers for molecular imaging. Amino Acids 2010; DOI: 10.1007/s00726-010-0546-y.
    • (2010) Amino Acids
    • Yan, Y.1    Chen, X.2
  • 15
    • 53349177489 scopus 로고    scopus 로고
    • Biomarkers for the lung cancer diagnosis and their advances in proteomics
    • Sung HJ, Cho JY. Biomarkers for the lung cancer diagnosis and their advances in proteomics. BMB Rep. 2008; 41: 615-625.
    • (2008) BMB Rep. , vol.41 , pp. 615-625
    • Sung, H.J.1    Cho, J.Y.2
  • 17
    • 43249088881 scopus 로고    scopus 로고
    • Update: improvement strategies for peptide receptor scintigraphy and radionuclide therapy
    • de Visser M, Verwijnen SM, de Jong M. Update: improvement strategies for peptide receptor scintigraphy and radionuclide therapy. Cancer Biother. Radiopharm. 2008; 23: 137-157.
    • (2008) Cancer Biother. Radiopharm. , vol.23 , pp. 137-157
    • de Visser, M.1    Verwijnen, S.M.2    de Jong, M.3
  • 18
    • 33947389680 scopus 로고    scopus 로고
    • Tropism modification of adenovirus vectors by peptide ligand insertion into various positions of the adenovirus serotype 41 short-fiber knob domain
    • Hesse A, Kosmides D, Kontermann RE, Nettelbeck DM. Tropism modification of adenovirus vectors by peptide ligand insertion into various positions of the adenovirus serotype 41 short-fiber knob domain. J. Virol. 2007; 81: 2688-2699.
    • (2007) J. Virol. , vol.81 , pp. 2688-2699
    • Hesse, A.1    Kosmides, D.2    Kontermann, R.E.3    Nettelbeck, D.M.4
  • 19
    • 41649083838 scopus 로고    scopus 로고
    • Targeted tumor diagnosis and therapy with peptide hormones as radiopharmaceuticals
    • Khan IU, Beck-Sickinger AG. Targeted tumor diagnosis and therapy with peptide hormones as radiopharmaceuticals. Anticancer Agents Med Chem. 2008; 8: 186-199.
    • (2008) Anticancer Agents Med Chem. , vol.8 , pp. 186-199
    • Khan, I.U.1    Beck-Sickinger, A.G.2
  • 20
    • 34548168881 scopus 로고    scopus 로고
    • Tumour-homing peptides: tools for targeting, imaging and destruction
    • Enback J, Laakkonen P. Tumour-homing peptides: tools for targeting, imaging and destruction. Biochem. Soc. Trans. 2007; 35: 780-783.
    • (2007) Biochem. Soc. Trans. , vol.35 , pp. 780-783
    • Enback, J.1    Laakkonen, P.2
  • 22
    • 55849131053 scopus 로고    scopus 로고
    • Update: molecular radiotherapy: survey and current status
    • Sgouros G. Update: molecular radiotherapy: survey and current status. Cancer Biother. Radiopharm. 2008; 23: 531-540.
    • (2008) Cancer Biother. Radiopharm. , vol.23 , pp. 531-540
    • Sgouros, G.1
  • 23
    • 17644401029 scopus 로고    scopus 로고
    • Usefulness of the novel oncofetal antigen glypican-3 for diagnosis of hepatocellular carcinoma and melanoma
    • Nakatsura T, Nishimura Y. Usefulness of the novel oncofetal antigen glypican-3 for diagnosis of hepatocellular carcinoma and melanoma. BioDrugs 2005; 19:71-77.
    • (2005) BioDrugs , vol.19 , pp. 71-77
    • Nakatsura, T.1    Nishimura, Y.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.